Tenpoint Therapeutics

United States · Biotech

Develops treatments to rejuvenate vision in the aging eye

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$235MAdBio — Role not disclosedBritish Business Bank — Role not disclosedEight Roads — Role not disclosedEQT Life Sciences — Role not disclosedEQT Nexus — Role not disclosedF-Prime — Role not disclosedHillhouse — Role not disclosedJanus Henderson — Role not disclosedQiming Venture Partners USA — Role not disclosedSofinnova Partners — Role not disclosedWille — Role not disclosed
Sourcestenpointtherapeutics.com ↗